Nuclear receptors regulate target gene expression by binding to their cognate DNA response elements in the control region of its target genes and recruiting associate proteins to the transcription machinery (1) (2) (3) . The associate proteins of nuclear receptors can be co-activators, co-repressors or co-regulators. A number of coactivators, mainly the p160 family, have been identified, including SRC-1/NCoA-1, TIF2/GRIP1/NCoA-2, and p/CIP/RAC3/ACTR/AIB1 (4) (5) (6) (7) (8) (9) (10) (11) (12) , several of which have been shown to encode intrinsic histone acetyl transferase activities (4, 5, 12) . On the contrary, corepressors are found to interact with histone deacetylases. For example, corepressors N-CoR/SMRT recruit histone deacetylases (HDACs) to remove specific acetyl groups from histone proteins of specific gene regulatory regions. As a result, chromatin is packed and gene activity is repressed (13, 14) . Upon ligand binding to receptors, the AF-2 domain (helix 12) is repositioned, co-repressors are released and coactivators are recruited to activate target gene expression. One mechanism of gene activation is believed to be mediated by relaxation of chromatin due to the action of acetyl transferase encoded by the coactivator complexes.
It was first suggested that the molecular basis underlying nuclear receptor interaction with co-activators involved a signature motif "LXXLL", where L is a leucine and X is any amino acid, present in many coactivators (15) (16) (17) (18) . By studying the X-ray crystal structure of a ternary complex formed by PPAR-γ, the ligand and a 88 amino acids peptide of coactivator SRC-1, it was found that a charge clamp was formed on the ligand binding domain of PPAR which made a direct contact with the backbone atoms of the LXXLL helices of SRC-1 (19) (20) (21) . Later, it was shown that aporeceptor interaction with corepressor involved a CoRNR box (L/IXXI/VI) (where L is a leucine, I is an isoleucine, V is a valine and X is any amino acid) found in co-repressors such as N-CoR and SMRT. However, in competition experiments, CoRNR peptides were able to block both co-repressor and coactivator interaction with nuclear receptors (22) , suggesting similar and probably overlapping receptor-interaction motif present in coactivators and corepressors. Furthermore, by studying mutant receptors and corepressors, it was found that mutations in nuclear receptor residues that directly participated in coactivator binding disrupted their interaction with corepressors (23, 24) . It was then suggested that a consensus LXXI/HIXXXI/L sequence of corepressors is an extended helix compared to the LXXLL helix found in coactivators, and both helices were able to interact with nuclear receptors in the same receptor pocket (24). 5 receptor (RAR) and retinoid receptor X (RXR), mediated by a C-terminal segment of RIP140 (27) . Two unique features of RIP140 are: a) In contrast to classical co-activators that interact with ligand bound hormone receptors to activate target gene expression, RIP140 suppressed gene activation by interacting with ligand-bound nuclear receptors in most reported studies (28) (29) (30) (31) , and b) The ligand-dependent receptor interacting motif of RIP140 does not involve any of its nine copies of LXXLL motif, rather it utilizes its C-terminal domain for holo-RAR/RXR interaction and a N-terminal amino acid (AA) #154-350 for Ah receptor interaction (26, 32) .
This study was aimed to first dissect the LXXLL-less motif of RIP140 that interacts with ligand bound RAR/RXR. This motif was determined by using different molecular approaches, including two-hybrid interaction, coimmunoprecipitation and GST-pull down assays. The functional role of this motif in the suppressive effects of RIP140 on RA induction of target gene expression was demonstrated in mutation studies. Finally, association of HDAC3, RIP140 and RAR/RXR was demonstrated to be ligand dependent in coimmunoprecipitation experiments, and histone acetylation decreased on the promoter region carrying an RA response element in the presence of RIP140. These data provided a molecular explanation for RIP140 acting as a novel ligand dependent negative modulator of RA regulated gene expression.
Experimental Procedures
Construction of expression vectors for mammalian two hybrid interaction tests RIP140 as well as its deletions was each fused to the Gal4 DNA binding domain of pM vector (Clontech, Palo Alto, CA) for dissecting the interacting domain by either restriction digestion or polymerase chain reaction (PCR) of RIP140 cDNA. The full length RIP (RIP-F), Nterminal domain AA #1-496 (RIP-N), central portion AA #496-1006 (RIP-cent) and C-terminal domain AA #977-1118 (RIP-C) were described previously (26) . R-18 was made by Hind III digestion of RIP-C, R-19 was made by Sma I digestion of R-18, and R-20 to R-32 were made by PCR cloning. The ligand binding domain of RAR and RXR was each fused to the pVP16 vector (Clontech, Palo Alto, CA) for two-hybrid test, the reporter (Gal4-luc) and the techniques for culturing COS-1 cells, transfection, and luciferase and lacZ assays were as described (26) .
Cultures were maintained in DMEM medium containing dextran charcoal-treated serum. Alltrans RA (at-RA) and 9-cis RA (9c-RA) was each added at a final concentration of 5 x 10 -7 M.
Each experiment was carried out in triplicate. At least three independent experiments were conducted to obtain the mean and the standard error of the mean. In vitro protein interaction test GST pull-down assay was conducted as described (24) . Various RIP140 segments as shown in Fig 
Results

In vivo ligand dependent RAR/RXR-interaction of RIP140 detected by two hybrid interaction tests
Previously, we have confirmed that RIP140 interaction with RAR and RXR depends upon the presence of ligands and utilizes a small C-terminal segment of RIP140 which lacks a typical LXXLL motif (27) . To determine the molecular basis of this ligand-dependent RIP140
interaction with RAR and RXR, we first utilized mammalian two-hybrid interaction tests. As shown in Fig Based upon these results, it is concluded that RIP140 interacts with RAR and RXR in a ligand dependent manner, and the interaction with liganded RAR and RXR is mediated by a small C-terminal peptide sequence (LTKTNPILYYMLQK), from AA # 1063 to A. A. # 1076.
In vitro ligand dependent interaction of RIP140 detected by GST pull down assays
To confirm the ligand-dependent RAR/RXR-interacting motif of RIP140, in vitro interaction tests based upon GST pull down assays were performed. In these tests, RIP140
portions were expressed as GST fusions and RAR/RXR was each expressed in TNT, with either one labeled with 35 S-Met. Fig. 2A shows the maps of the representative clones, Fig. 2B shows the GST pull-down experiments that utilized labeled RAR and Fig. 2C shows the Coomassie blue stained gel separating partially purified RIP fragments (labeled with "*" signs on the right).
As shown in Fig. 2B, all Therefore, it is concluded that the C-terminal AA #1063-1076 of RIP140 is a ligand-dependent, specific RAR/RXR interacting motif.
Functional role of receptor interacting motif of RIP140 in suppression of RA induction
The biological activity of RIP140 in hormone receptor actions has been controversial. In the RAR/RXR system, we have consistently observed a ligand-dependent interaction of RIP140 with RAR and RXR heterodimers, which resulted in strongly suppressed RA induction of reporter activities (27) . To determine if the interaction of RAR/RXR is required for the biological activity of RIP140, represented as suppression of RA-induced reporter activity, a mutant RIP140 (L-384) was constructed that was deleted specifically in the region AA#1063-1076. Transfection experiments were conducted to determine RA induction of reporter activities in the presence of RIP140 or this mutant as shown in Fig. 4 . Consistent with our previous observations, RA induced reporter activities for greater than 50 folds (columns 1 and 2). In the presence of wild type RIP140, the basal level reporter activity remained the same in the absence of RA (column 3), but RA-indcued reporter activity decreased for more than 20 folds (column 4). Very differently, the mutant, L-384, failed to effectively suppress RA induction (columns 5 and 6).
This result confirmed that the suppressive effect of RIP140 on RA reporters was mediated by its To monitor the efficiency of protein expression in these cultures, total lysates were examined on the same blots for the expression of each component as shown on lanes 1-3 and 7. This result strongly supports our hypothesis that RIP140 facilitates immunocomplex formation of HDAC3 with RAR/RXR in the presence of RA and that the C-terminal receptor-interacting motif of RIP140 is required for this activity.
Deacetylation of RA responsive promoter by RA in the presence of RIP140 Our demonstrations of HDAC activity in the immunoprecipitates of anti-RIP140 (33) and RA induced complex formation of RIP140, HDAC3 and holo-RAR/RXR (Fig. 5) would predict decreased acetylation of chromatin histones around the promoter region of RAR/RXR target genes in the presence of RIP140 and RA. To test this possibility, we employed ChIP assays by using a classical DR5-tk reporter as a model, which was also used to examine the biological activity of RIP140 on RA regulated target gene expression (Fig. 4) . In this assay, acetylated chromatin can be precipitated with anti-acetyl H3 and the precipitated DNA fragments detected by PCR. On the contrary, hypoacetylated chromatin is precipitated less efficiently, therefore, less RIP140 constructs generated as GST fusions. Results from the pull down assays are shown at the right hand column. B) GST pull-down assay by using labeled RAR and unlabeled RXR. C) A protein gel demonstrating the presence of GST fusion protein in each construct, as marked with "*" signs. and RXR (bottom panel) was conducted using 100 µM of peptide in the reactions. 
